XenoPort to Release Third Quarter Financial Results on November 7
October 30 2013 - 5:00PM
Business Wire
XenoPort, Inc. (Nasdaq: XNPT) announced today that it will
release its third quarter financial results on November 7, 2013 at
approximately 4:30 p.m. Eastern Time. The company will host a
conference call at 5:00 p.m. Eastern Time that same day to provide
a summary of its financial results, general business updates and a
review of additional clinical data and program developments for
XP23829, XenoPort’s novel fumaric acid ester product candidate.
To access the conference call via the Internet, go to
www.XenoPort.com. Please join the call at least 15 minutes prior to
the start to ensure time for any software downloads that may be
required.
To access the live conference call via phone, dial
1-888-275-3514. International callers may access the live call by
dialing 706-679-1417. The reference number to enter the call is
77314561.
A replay of the conference call will be available for one week
following the event and may be accessed after 8:00 p.m. Eastern
Time that same day via the Internet, at www.XenoPort.com, or via
phone at 1-855-859-2056 for domestic callers, or 404-537-3406 for
international callers. The reference number to enter the replay of
the call is 77314561.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on
developing and commercializing a portfolio of internally discovered
product candidates for the potential treatment of neurological
disorders. XenoPort is currently commercializing HORIZANT®
(gabapentin enacarbil) Extended-Release Tablets in the United
States and developing its novel fumaric acid ester product
candidate, XP23829, as a potential treatment for
relapsing-remitting multiple sclerosis and/or psoriasis. REGNITE®
(gabapentin enacarbil) Extended-Release Tablets is being marketed
in Japan by Astellas Pharma Inc. XenoPort's pipeline of product
candidates includes potential treatments for patients with
spasticity related to spinal cord injury and Parkinson's disease.
To learn more about XenoPort, please visit the Website at
www.XenoPort.com.
HORIZANT, REGNITE and XENOPORT are registered trademarks of
XenoPort, Inc.
XNPT2F
XenoPort, Inc.Jackie Cossmon, 408-616-7220ir@XenoPort.com
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Xenoport, Inc. (NASDAQ:XNPT)
Historical Stock Chart
From Sep 2023 to Sep 2024